CD34&CD38 most immature subpopulations may increase with poor-prognosis markers in both adults and the elderly.<h4>Conclusions</h4>Repositioning immunophenotypic analyses may offer a cost-effective alternative for refined prognostication, particularly in healthcare centers that already have flow cytometry-based AML diagnostics. Here, CD38 is linked to acute myeloid leukemia.